Sotabase

Career

· Visiting Researcher, Mayo Clinic2001–2002
· Director of the Center for Retailing Studies, Texas A&M University1982–2000
· University Distinguished Professor of Marketing, Texas A&M University Mays Business School1982–
· PhD Student, Arizona State University
· Senior Quality Advisor, Henry Ford Health
· Senior Fellow, Institute for Healthcare Improvement
· BA, University of Denver
· MBA, University of Denver
· Adjunct Professor, Faculty of Health Sciences, University of Southern Denmark

Publications (389)

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Journal of the American Medical Association (JAMA) · 2014
1,597
cited
of Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
2021
842
cited
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021
693
cited
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine · 2021
679
cited
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
The Lancet · 2021
562
cited
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
The Lancet · 2021
543
cited
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
Cell · 2020
434
cited
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience
Journal of Thoracic Oncology · 2015
365
cited
Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Journal of Clinical Oncology · 2013
209
cited
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA) · 2021
202
cited
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations—The Lung Cancer Mutation Consortium (LCMC2)
Clinical Cancer Research · 2017
167
cited
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase.
Journal of Medicinal Chemistry · 2008
131
cited
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA) · 2022
113
cited
Inhibition of Inducible Liver Enzymes by Endotoxin and Actinomycin D
Journal of Bacteriology · 1966
97
cited
Studies of onion root respiration I. Velocity of oxygen consumption in different segments of root at different temperatures as a function of partial pressure of oxygen
1949
95
cited
Discovery of a potent, selective, and orally bioavailable c-Met inhibitor: 1-(2-hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458).
Journal of Medicinal Chemistry · 2008
90
cited
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Intensive Care Medicine · 2021
88
cited
Systemic and gastrointestinal candidiasis of infant mice after intragastric challenge
Infection and Immunity · 1979
84
cited
Effects of Endotoxin on Gluconeogenesis, Glycogen Synthesis, and Liver Glycogen Synthase in Mice
Infection and Immunity · 1973
77
cited
Persistence and spread of Candida albicans after intragastric inoculation of infant mice
Infection and Immunity · 1981
69
cited
Sotabase